Development of novel 1,2,3,4-tetrahydroquinoline scaffolds as potent NF-κB inhibitors and cytotoxic agents

Cited 30 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorH Jo-
dc.contributor.authorM Choi-
dc.contributor.authorA S Kumar-
dc.contributor.authorY Jung-
dc.contributor.authorS Kim-
dc.contributor.authorJieun Yun-
dc.contributor.authorJong Soon Kang-
dc.contributor.authorY Kim-
dc.contributor.authorS B Han-
dc.contributor.authorJ K Jung-
dc.contributor.authorJ Cho-
dc.contributor.authorK Lee-
dc.contributor.authorJ H Kwak-
dc.contributor.authorH Lee-
dc.date.accessioned2017-04-19T10:20:17Z-
dc.date.available2017-04-19T10:20:17Z-
dc.date.issued2016-
dc.identifier.issn1948-5875-
dc.identifier.uri10.1021/acsmedchemlett.6b00004ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/13229-
dc.description.abstract1,2,3,4-Tetrahydroquinolines have been identified as the most potent inhibitors of LPS-induced NF-κB transcriptional activity. To discover new molecules of this class with excellent activities, we designed and synthesized a series of novel derivatives of 1,2,3,4-tetrahydroquinolines (4a-g, 5a-h, 6a-h, and 7a-h) and bioevaluated their in vitro activity against human cancer cell lines (NCI-H23, ACHN, MDA-MB-231, PC-3, NUGC-3, and HCT 15). Among all synthesized scaffolds, 6g exhibited the most potent inhibition (53 times that of a reference compound) of LPS-induced NF-κB transcriptional activity and the most potent cytotoxicity against all evaluated human cancer cell lines.-
dc.publisherAmer Chem Soc-
dc.titleDevelopment of novel 1,2,3,4-tetrahydroquinoline scaffolds as potent NF-κB inhibitors and cytotoxic agents-
dc.title.alternativeDevelopment of novel 1,2,3,4-tetrahydroquinoline scaffolds as potent NF-κB inhibitors and cytotoxic agents-
dc.typeArticle-
dc.citation.titleACS Medicinal Chemistry Letters-
dc.citation.number4-
dc.citation.endPage390-
dc.citation.startPage385-
dc.citation.volume7-
dc.contributor.affiliatedAuthorJieun Yun-
dc.contributor.affiliatedAuthorJong Soon Kang-
dc.contributor.alternativeName조혜주-
dc.contributor.alternativeName최민호-
dc.contributor.alternativeNameKumar-
dc.contributor.alternativeName정영은-
dc.contributor.alternativeName김상은-
dc.contributor.alternativeName윤지은-
dc.contributor.alternativeName강종순-
dc.contributor.alternativeName김영수-
dc.contributor.alternativeName한상배-
dc.contributor.alternativeName정재경-
dc.contributor.alternativeName조정숙-
dc.contributor.alternativeName이기호-
dc.contributor.alternativeName곽재환-
dc.contributor.alternativeName이희순-
dc.identifier.bibliographicCitationACS Medicinal Chemistry Letters, vol. 7, no. 4, pp. 385-390-
dc.identifier.doi10.1021/acsmedchemlett.6b00004-
dc.subject.keyword1,2,3,4-Tetrahydroquinolines-
dc.subject.keywordhuman cancer cell lines-
dc.subject.keywordin vitro cytotoxicity-
dc.subject.keywordNF-κB inactivation-
dc.subject.local1,2,3,4-Tetrahydroquinolines-
dc.subject.localHuman cancer cell line-
dc.subject.localhuman cancer cell lines-
dc.subject.localHuman cancer cell lines-
dc.subject.localin vitro cytotoxicity-
dc.subject.localNF-κB inactivation-
dc.description.journalClassY-
Appears in Collections:
Ochang Branch Institute > Division of National Bio-Infrastructure > Laboratory Animal Resource & Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.